🇨🇦 Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide in Canada

Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide (Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide) regulatory status in Canada.

Marketing authorisation

Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide in Canada?

Wyeth is now a wholly owned subsidiary of Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.